Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission

Key Points

• Children in remission from nephrotic syndrome showed specific changes in apolipoproteins and dyslipidemia markers.
• The study identified significant differences in lipoprotein(a) levels in relation to conventional markers of dyslipidemia.
• Observational analysis assessed lipid profiles and biomarkers in children diagnosed with nephrotic syndrome.
• Findings highlight the need for ongoing monitoring of dyslipidemia to manage health outcomes in this population.